Xeris Biopharma Holdings, Inc. — Form 8-K
Filed October 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 5/100
What the filing says
Xeris Biopharma filed an 8-K on 2026-10-14 reporting other events as of 2026-10-13. The actual substance of Item 8.01 is not provided in the document index or header—only the filing metadata, document file list, and company registration details are shown. No specific business development, transaction, financial impact, or operational change is disclosed in the materials provided.
Why this rating
No material facts disclosed; Item 8.01 content absent from filing text. Routine administrative disclosure.
Extracted items
See more from October 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.